SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Cancer Therapy–Related Cardiac DysfunctionVennela Avula, Sarju Ganatra, Lauren A. Baldassarre et al.|JACC Heart Failure|2023Cited by 100
Immune checkpoint inhibitor-associated myocarditis: a novel risk scoreJohn R. Power, Anju Nohria, Charles Dolladille et al.|European Heart Journal|2025Cited by 34
Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network surveyKerry Skurka, Diego Sadler, Jeanne M. DeCara et al.|Cardio-Oncology|2020Cited by 28
The COVID-19 Pandemic Impact on Cardio-Oncology: Results From the COVID-19 International Collaborative Network Survey.Diego Sadler, Susan Dent, Jeanne M. DeCara et al.|Research Square|2020Cited by 3